Foghorn Therapeutics Inc. (FHTX) — Stock Score Summary

Foghorn Therapeutics Inc. (FHTX) has a MoatMap StockRank of 13/100 based on Quality (19/100), Value (43/100), and Momentum (35/100) factor scores. The current signal is STRONG SELL.

Foghorn Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel therapeutics targeting the chromatin regulatory system for cancer and other serious diseases. The company's proprietary Gene Traffic Control® platform identifies and validates targets within this system, offering a differentiated approach to drug discovery. Foghorn is a niche player in epigenetics, aiming to unlock new treatment modalities for difficult-to-treat diseases through precision medicine.

Key Financial Metrics

Price$4.04
Market Cap$276M
P/E (Forward)-4.66
Price/Book-2.26
Return on Invested Capital-59.3%
Gross Margin-190.9%
Operating Margin-660.3%
Revenue Growth-45.1%
Free Cash Flow$-37M

Foghorn Therapeutics Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Foghorn Therapeutics Inc.’s (FHTX) StockRank?
MoatMap’s StockRank for Foghorn Therapeutics Inc. (FHTX) is 13/100, with a Strong Sell signal. It is a composite of Quality (19), Value (43), and Momentum (35) factor ranks across MoatMap’s 15,000+ stock universe.
Does Foghorn Therapeutics Inc. have an economic moat?
Foghorn Therapeutics Inc. (FHTX) has a Quality factor score of 19/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Foghorn Therapeutics Inc. a buy, hold, or sell?
MoatMap’s current signal for Foghorn Therapeutics Inc. (FHTX) is Strong Sell, based on a StockRank of 13/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Foghorn Therapeutics Inc. in?
Foghorn Therapeutics Inc. (FHTX) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksFHTX deep dive reportAI ChampionsHow we score stocksSense-check another stock